Literature DB >> 23372945

The impact of decreasing cutoff values for maximal oxygen consumption (VO(2)max) in the decision-making process for candidates to lung cancer surgery.

Gaetano Rocco1, Tindaro Gatani, Massimo Di Maio, Ilernando Meoli, Antonello La Rocca, Nicola Martucci, Carmine La Manna, Francesco Stefanelli.   

Abstract

BACKGROUND: Maximal oxygen consumption (VO(2)max) is considered a decisive test for risk prediction in patients with borderline cardiopulmonary reserve. Guidelines have adopted decreasing VO(2)max cut-off values to define operability within acceptable mortality and morbidity limits. We wanted to investigate how the adoption of decreasing VO(2)max cut-off-values assessment contributed to better select lung surgery candidates.
METHODS: One hundred and nineteen consecutive surgical candidates have been prospectively analyzed as a sample population. Preoperative work-up included spirometry and transfer factor (DLco); irrespective of the spirometric values, these patients were subjected to VO(2)max assessment. Surgical eligibility was decided by the same surgeon throughout the series. In the postoperative period, overall mortality and the occurrence of any, major or minor complications was recorded and graded according to the Common Terminology Criteria for Adverse Events v.4.3.
RESULTS: Three arbitrary cut-offs were introduced at 15, 14 and 12 mL(.)kg(-1) (.)min(-1). Notably, 15 and 12 mL(.)kg(-1) (.)min(-1) correlated with percentage VO(2)max values of 50% and 35% of predicted (P<0.0001 and 0.0079), respectively. Accordingly, the patients were subdivided into groups in which the prevalence of postoperative morbidity was recorded. The groups were homogeneous as to age, BMI, preoperative absolute and percentage FEV1 and DLco. In the Cox proportionate-hazards multivariate analysis, VO(2)max less than 35% (P=0.0017) and CTCAE >2 (P=0.0457) emerged as significant predictors of survival after surgery. Conversely on logistic regression analysis, age over 70 years (P=0.03) and pneumonectomy (P=0.001), but not VO(2)max cut-off values, were significant predictors of major (CTCAE >2) morbidity.
CONCLUSIONS: Since VO(2)max is increasingly used to contribute to risk prediction for the individual patient, surgeons need to be advised that the concept of a definitive, generalized cut-off value for VO(2)max is probably a contradiction in terms. Patient-specific VO(2)max values are more likely to contribute to risk assessment since they may reflect the primarily affected component among the determinants of maximal oxygen consumption. Whether patient-specific VO(2)max should be routinely used by surgeons to define operability for borderline patients needs further evaluation.

Entities:  

Keywords:  Maximal oxygen consumption; lung cancer; lung surgery

Year:  2013        PMID: 23372945      PMCID: PMC3548002          DOI: 10.3978/j.issn.2072-1439.2012.12.04

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

2.  Identification of prognostic factors determining risk groups for lung resection.

Authors:  A Bernard; L Ferrand; O Hagry; L Benoit; N Cheynel; J P Favre
Journal:  Ann Thorac Surg       Date:  2000-10       Impact factor: 4.330

Review 3.  Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery.

Authors:  I M Weisman
Journal:  Semin Thorac Cardiovasc Surg       Date:  2001-04

Review 4.  ATS/ACCP Statement on cardiopulmonary exercise testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-01-15       Impact factor: 21.405

5.  Internal validation of risk models in lung resection surgery: bootstrap versus training-and-test sampling.

Authors:  Alessandro Brunelli; Gaetano Rocco
Journal:  J Thorac Cardiovasc Surg       Date:  2006-06       Impact factor: 5.209

6.  Risk model of in-hospital mortality after pulmonary resection for cancer: a national database of the French Society of Thoracic and Cardiovascular Surgery (Epithor).

Authors:  Alain Bernard; Caroline Rivera; Pierre Benoit Pages; Pierre Emmanuel Falcoz; Eric Vicaut; Marcel Dahan
Journal:  J Thorac Cardiovasc Surg       Date:  2010-08-09       Impact factor: 5.209

7.  Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude.

Authors:  Trond-Eirik Strand; Hans Rostad; Ronald A M Damhuis; Jarle Norstein
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

8.  Nutritional status affects long term survival after lobectomy for lung cancer.

Authors:  Nilanjana Tewari; Antonio E Martin-Ucar; Edward Black; Lynda Beggs; F David Beggs; John P Duffy; W Ellis Morgan
Journal:  Lung Cancer       Date:  2007-05-03       Impact factor: 5.705

9.  Obesity does not increase complications after anatomic resection for non-small cell lung cancer.

Authors:  Philip W Smith; Hongkun Wang; Leo M Gazoni; K Robert Shen; Thomas M Daniel; David R Jones
Journal:  Ann Thorac Surg       Date:  2007-10       Impact factor: 4.330

10.  Anticoagulation by ancrod for carbon dioxide removal by extracorporeal membrane lung in the dog.

Authors:  M E Sinclair; G Reber; A Schweizer; K L Dorrington; P De Moerloose; C A Bouvier; J P Gardaz
Journal:  J Thorac Cardiovasc Surg       Date:  1989-02       Impact factor: 5.209

View more
  3 in total

1.  Patient selection for operation: the complex balance between information and intuition.

Authors:  Alessandro Brunelli; Cecilia Pompili; Michele Salati
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

2.  Prediction of postoperative cardiopulmonary complications after lung resection in a Chinese population: A machine learning-based study.

Authors:  Guanghua Huang; Lei Liu; Luyi Wang; Shanqing Li
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

3.  Can functional inoperability in lung cancer patients be changed by pulmonary rehabilitation?

Authors:  Esra Pehlivan; Arif Balcı; Lütfiye Kılıç
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-04-24       Impact factor: 0.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.